News

11 September 2018

MHRA statement on notifying the BNF of updates to SmPCs and PILs

In response to an enquiry from a PIPA member, PIPA contacted the MHRA to provide clarification of whether it is a requirement for Marketing Authorisation Holders to notify the BNF of SmPC and PIL updates.  We have received the following resp...

30 August 2018

PMCPA announce launch of consultation period for proposed changes to ABPI Code of Practice

On 29th August, the PMCPA announced the launch of the consultation period for their proposed changes to the ABPI Code of Practice and the PMCPA Constitution and Procedure. The proposed changes are to ensure that the Code reflects UK law and incor...

15 August 2018

UKMi Twitter Feed

UK Medicines Information (UKMi) have launched a Twitter account. You can now follow them via @UKMedicinesInfo. 

13 August 2018

MHRA Guidance on Brexit Implementation and ABPI Response

On 6th August, the MHRA published guidance on what the Brexit implementation period means for the life science sector: https://www.gov.uk/guidance/technical-information-on-what-the-implementation-period-means-for-the-life-science-sector The docu...

02 February 2017

ABPI: UK pharmaceutical industry response to new Brexit White Paper

Mike Thompson, ABPI Chief Executive, has issued a statement in response to the publication of 'The United Kingdom’s Exit from, and New Partnership with, the European Union’ White Paper. For full details, go...